Collegium Pharmaceutical (COLL) Receivables - Other (2014 - 2026)

Collegium Pharmaceutical's Receivables - Other history runs 4 years deep, the most recent figure standing at $19.8 million for Q1 2026.

• In Q1 2026, Receivables - Other changed N/A year-over-year to $19.8 million; the TTM figure through Mar 2026 stood at $19.8 million (changed N/A YoY), while the FY2025 annual figure was $19.8 million, down 20.6% from the prior year.
• Receivables - Other was $19.8 million for Q1 2026 at Collegium Pharmaceutical, roughly flat from $19.8 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $25.0 million in Q4 2024 to a low of $19.8 million in Q4 2025.
• Historically, Receivables - Other has averaged $21.6 million across 3 years, with a median of $19.8 million in 2025.
• Biggest YoY gain for Receivables - Other was 20.6% in 2025; the steepest drop was 20.6% in 2025.
• A 3-year view of Receivables - Other shows it stood at $25.0 million in 2024, then slipped by 20.6% to $19.8 million in 2025, then changed by 0.0% to $19.8 million in 2026.
• The last three Receivables - Other figures came in at $19.8 million (Q1 2026), $19.8 million (Q4 2025), and $25.0 million (Q4 2024), per Business Quant data.